Cholera Vaccines; Work group introduction; Public Comment; Vote; Zoster Vaccine; Update on post-licensure safety monitoring of recombinant
zoster vaccine (RZV, Shingrix) in the Vaccine Adverse Event
Reporting System (VAERS); Vaccine Safety Datalink (VSD) update on post-licensure safety monitoring of RZV; Risk of Guillain-Barré syndrome following herpes zoster; Summary and planned risk-benefit analysis regarding use of RZV in immunocompetent adult; Planned risk-benefit analysis regarding use of RZV in immunocompetent adults
Comments on this video are allowed in accordance with our comment policy:
http://www.cdc.gov/SocialMedia/Tools/CommentPolicy.html
This video can also be viewed at
